Gloria Huang

Gloria Huang, MD

Specialty

Gynecologic Oncology

Medical School

Stanford University

Residency

Stanford Hospitals and Clinics

Fellowship

Albert Einstein College of Medicine

Board Certifications

  • Gynecologic Oncology - American Board of Obstetrics and Gynecology
  • Obstetrics and Gynecology - American Board of Obstetrics and Gynecology

Locations

More about Gloria Huang, MD

Biography

Dr. Gloria Huang provides gynecologic oncology care to patients at Stamford Hospital. She’s an internationally renowned expert in treating and preventing reproductive tract cancers, including ovarian, uterine and cervical cancer. Her individualized approach to care incorporates minimally invasive surgical techniques and scientifically guided strategies to achieve the best clinical outcomes.

Dr. Huang works to develop innovative treatments for women with ovarian and uterine cancer. She has published 35 peer-reviewed research articles, chapters and reviews, and has presented her findings nationally and internationally. She’s also a principal investigator of a federally funded cancer research laboratory.

Dr. Huang is active in several national organizations. She currently serves on the Society of Gynecologic Oncology Publications Committee and formerly served on their education committee.

Special Interests

  • Ovarian cancer
  • Uterine cancer
  • Cervical cancer

Published Work

Mi S, Lin M, Brouwer-Visser J, Heim J, Smotkin D, Hebert T, Gunter MJ, Goldberg GL, Zheng D, Huang GS: “RNA-seq identification of RACGAP1 as a metastatic driver in uterine carcinosarcoma” (Clinical Cancer Research. 2016 Sep 15;22(18):4676-86)

 

Merritt MA, Strickler HD, Einstein MH, Yang H, Sherman ME, Wentzensen N, Brouwer-Visser J, Cossio MJ, Whitney K, Yu H, Sgueglia R, Gunter MJ, Huang GS: “Characterization of the Insulin-IGF and Sex Hormone Axes in Human Endometrium and Associations with Endometrial Cancer Risk Factors” (Cancer Causes & Control. 2016 Jun;27(6):737-48)

 

Schwartz, MA, Huang GS: “Retreatment with aromatase inhibitor therapy in the management of granulosa cell tumor” (Gynecol Oncol Rep. 2015 Dec 28;15:20-1)

 

Yang HP, Meeker A, Guido R, Gunter MJ, Huang GS, Luhn P, d’Ambrosio L, Wentzensen N, Sherman ME: “PTEN expression in benign human endometrial tissue and cancer in relation to endometrial cancer risk factors” (Cancer Causes & Control. 2015 Dec;26(12):1729-36)

 

Brouwer-Visser J, Huang GS: “IGF2 signaling and regulation in cancer” (Cytokine and Growth Factor Reviews. 2015 Jun; 26(3):371-7)

 

Brouwer-Visser J, Lee J, McCullagh K, Cossio MJ, Huang GS: “Insulin-like Growth Factor 2 silencing restores sensitivity in drug resistant ovarian cancer” (PLoS One. 2014; Jun 9(6): e100165)

 

Einstein MH, Klobocista M, Hou JY, Lee S, Mutyala S, Mehta K, Reimers LL, Kuo DYS, Huang GS, Goldberg GL: “Phase II trial of adjuvant pelvic radiation “sandwiched” between ifosfamide or ifosfamide plus cisplatin in women with uterine carcinosarcoma” (Gynecologic Oncology. 2012 Jan;124(1):26-30)

 

Gupta D, Gunter MJ, Yang K, Lee S, Zuckerwise L, Chen L, Goldberg GL, Huang GS: “Performance of serum CA125 as a prognostic biomarker in patients with uterine papillary serous carcinoma” (International Journal of Gynecological Cancer. 2011 Apr; 21(3):529-534)

 

Huang GS, Gunter MJ, Arend RC, Li M, Arias-Pulido H, Prossnitz ER, Goldberg GL, Smith HO: “Co-expression of GPR30 and ERb and their association with disease progression in uterine carcinosarcoma” (American Journal of Obstetrics and Gynecology. 2010 Sept; 203:242.e1-5)

 

Huang GS, Brouwer-Visser J, Ramirez MJ, Kim CH, Hebert TM, Lin J, Arias-Pulido H, Qualls CR, Prossnitz ER, Goldberg GL, Smith HO, Horwitz SB: “Insulin-like growth factor 2 (IGF2) expression modulates Taxol resistance and is a candidate biomarker for reduced disease-free survival in ovarian cancer” (Clinical Cancer Research. 2010 Jun 1; 16(11):2999-3010)

 

Huang GS, Arend RC, Li M, Gunter MJ, Chiu LG, Horwitz SB, Goldberg GL: “Tissue Microarray Analysis of Hormonal Signaling Pathways in Uterine Carcinosarcoma” (American Journal of Obstetrics and Gynecology. 2009 Apr; 200(4):457.e1-5)

 

Huang GS, Chiu LG, Gebb JS, Gunter MJ, Sukumvanich P, Goldberg GL, Einstein MH: “Serum CA125 predicts extrauterine disease and survival in uterine carcinosarcoma” (Gynecologic Oncology. 2007 Dec; 107(3):513-7)

 

Huang GS, Gebb JS, Einstein MH, Shahabi S, Novetksy AP, Goldberg GL: “Accuracy of pre-operative endometrial sampling for the detection of high-grade endometrial tumors” (American Journal of Obstetrics and Gynecology. 2007 Mar; 196:243.e1-243.e5)

 

Einstein MH, Novetsky AP, Garg M, Hailpern SM, Huang GS, Glueck A, Fields AL, Kalnicki S, Goldberg GL: “Survival and toxicity differences between 5-day and weekly cisplatin in patients with locally advanced cervical cancer” (Cancer. 2007 Jan; 109(1):48-53)

 

Huang GS, Lopez-Barcons L, Freeze S, Smith AB, Goldberg GL, Horwitz SB, McDaid HM: “Potentiation of Taxol efficacy by discodermolide in ovarian carcinoma xenograft-bearing mice” (Clinical Cancer Research. 2006 Jan; 12(1):298-304)

Affiliations

  • American Association of Cancer Research
  • American College of Obstetrics and Gynecology
  • American Medical Association
  • American Society of Clinical Oncology
  • International Gynecologic Cancer Society
  • NRG Oncology/Gynecologic Oncology Group
  • Society of Gynecologic Oncology
  • Society of Reproductive Investigation

Academic Appointment

Associate Professor in the Department of Obstetrics, Gynecology, and Reproductive Sciences at Yale School of Medicine

Languages

English, Spanish (proficient), and Mandarin Chinese (basic)

If you are in need of emergency care, call 911.

The majority of the physicians on the Stamford Hospital Medical Staff are not employees or agents of the Hospital. They are independent practitioners who have been granted the privilege of using the Hospital's facilities for the care and treatment of their patients. This includes, but is not limited to, emergency department physicians, anesthesiologists, radiologists, surgeons, cardiologists, obstetricians, pathologists and other consultants who may treat patients.

Insurance listings are subject to change at any time. Please verify insurance plan acceptance when scheduling an appointment with a healthcare provider.

Read important information on Non-discrimination and Interpreter Services and visit Patients Rights.